Rock Springs Capital Management LP Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$2.4B
Holdings
131
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (131 positions)
| Stock | Value |
|---|---|
—PARATEK PHARMACEUTICALS INC | $4.8M |
AKROAKERO THERAPEUTICS INC | $4.8M |
GRTXGALERA THERAPEUTICS INC | $4.8M |
TXG10X GENOMICS INC | $4.7M |
NGMUSDNGM BIOPHARMACEUTICALS INC | $4.3M |
OSWONESPAWORLD HOLDINGS LIMITED | $4.3M |
ANABANAPTYSBIO INC | $4.2M |
IMVTIMMUNOVANT INC | $3.9M |
—MYOVANT SCIENCES LTD | $3.8M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $3.7M |
—PHASEBIO PHARMACEUTICALS INC | $3.7M |
PASGPASSAGE BIO INC | $3.5M |
—OBSEVA SA | $3.4M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $3.3M |
AXNX*AXONICS MODULATION TECHNOLOG | $3.2M |
TREURTRILLIUM THERAPEUTICS INC | $3.0M |
—GAMIDA CELL LTD | $3.0M |
—GLOBAL CORD BLOOD CORPORATIO | $2.9M |
—GW PHARMACEUTICALS PLC | $2.6M |
TVTX 2.5 09/15/25RETROPHIN INC | $2.6M |
ACRSACLARIS THERAPEUTICS INC | $1.7M |
XLRNACCELERON PHARMA INC | $1.6M |
—THERAVANCE BIOPHARMA INC | $1.4M |
MGNXMACROGENICS INC | $1.3M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.3M |
—RADIUS HEALTH INC | $1.1M |
—PACIRA BIOSCIENCES | $966K |
—FIVE PRIME THERAPEUTICS INC | $908K |
BMY-RBRISTOL-MYERS SQUIBB CO | $704K |
—NABRIVA THERAPEUTICS PLC | $604K |
CVETUSDCOVETRUS INC | $168K |
PreviousPage 2 of 2